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RESUMO
Os objetivos deste estudo foram: caracteri-
zar a polifarmácia entre portadores de Dia-
betes Mellitus tipo2(DM2); e correlacionar
polifarmácia e número de complicações do
DM2 com indicadores de depressão (Inven-
tário de Depressão de Beck[IDB] e cortisol
urinário[CORT]). A amostra foi composta por
40 pacientes da Liga de Diabetes do HCFM-
USP, avaliados quanto aos indicadores de
depressão (CORT e IDB) e quanto à prática
de polifarmácia e número de complicações
do DM2. Os resultados mostraram que os
medicamentos utilizados foram: antidiabé-
ticos orais, insulinas, anti-hipertensivos, diu-
réticos, anti-lipêmicos e trombolíticos. No
grupo estudado, 75% fizeram uso diário de
5 a 8 medicamentos, e 12,5% de 8 medica-
mentos/dia ou mais; todos fizeram no míni-
mo 3 tomadas diárias, 60% tinham entre 1 e
3 complicações do DM2, e 22,5% tinham 3
ou mais. A correlação entre os indicadores
de depressão(IDB e CORT), o número de me-
dicamentos e o número de complicações do
DM2 não foi estatisticamente significante.
No entanto, houve correlação positiva entre
CORT  e número de tomadas diárias de medi-
camentos (Spearman,r=0.319, p=0.019).
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ABSTRACT
The objectives of this study were: to charac-
terize the polipharmacy in subjects with Type
2 Diabetes Mellitus (DM2) and to verify the
correlation between polipharmacy and num-
ber of medications for DM2 complications
with depression indicators (Beck Depression
Inventory (BDI) and urinary cortisol (CORT)
levels). A sample composed of 40 patients
with DM2 from the Diabetes League of HCFM-
USP was analyzed for depression indicators
(CORT and BDI) in addition to evaluation for
polipharmacy and number of DM2 compli-
cations. The results showed oral hypoglyce-
mic agents, insulins, antihypertensives, di-
uretics, lipid-lowering drugs and throm-
bolytics are the most frequent medications
used. In this sample, 75% used from 5 to 8
medicines daily and 12.5% used more than
eight medicines/day; all of them used to take
each medication at least 3 times daily. Be-
tween 1 and 3 DM2 complications were ob-
served in 60% of the individuals and 22.5%
showed more than 3 DM2 complications. No
significant correlations were observed be-
tween depression indicators (BDI and CORT),
number of medications and DM2 complica-
tions. However, positive correlation was ob-
served between CORT and daily frequency of
medication (Spearman, r=0.319, p=0.019).
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RESUMEN
Fueron objetivos de este estudio: caracteri-
zar a la polifarmacia entre portadores de Dia-
betes Mellitus tipo 2 (DM2) y correlacionar la
polifarmacia y el número de complicaciones
de la DM2 con indicadores de depresión (In-
ventario de Depresión de Beck [IDB] y cortisol
urinario [CORT]). La muestra fue integrada por
40 pacientes de la Liga de Diabetes del HCFM-
USP evaluados respecto de los indicadores de
depresión (CORT e IDB) y también en cuanto
a la práctica de polifarmacia y número de
complicaciones de la DM2. Los resultados
mostraron que los medicamentos utilizados
fueron: antidiabéticos orales, insulinas,
antihipertensivos, diuréticos, antilipemiantes
y trombolíticos. Dentro del grupo estudiado,
75% de los pacientes utilizaban diariamente
entre 5 y 8 medicamentos, un 12,5% de la
muestra hacía uso de 8 medicamentos/día o
más; todos hicieron como mínimo tres tomas
diarias, el 60% presentaba entre 1 y 3 compli-
caciones de la DM2 y el 22,5% presentaba 3
o más. La correlación entre los indicadores de
depresión (IDB y CORT) y el número de medi-
camentos y de complicaciones de la DM2 no
fue estadísticamente significativa. Sin embar-
go, hubo correlación positiva entre CORT y la
cantidad de tomas diarias de medicamentos
(Spearman, r=0.319, p=0.019).
DESCRIPTORES
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INTRODUCTION
Diabetes Mellitus is a widespread chronic disease. Ac-
cording to the International Diabetes Federation, it affects
approximately 140 million people throughout the world and
it is estimated to reach 300 million by 2025(1).
In Brazil, Diabetes Mellitus prevalence in the popula-
tion between 30 to 69 years old is of 7.6%, representing 10
million people. Within these people, 90% are carriers of
Diabetes Mellitus Type 2 (DM2) (2). A more recent study
developed in Ribeirão Preto using more restricted glyce-
mic limits according to current recommendations, demon-
strated a prevalence of 12.1% in similar population(3).
Chronic complications from the disease include
macroangiopathy, microangiopathy and peripheral and
autonomic neuropathies (4).
The United Kingdom Prospective Diabetes Study
(UKPDS) was the most important multicentric study car-
ried out with DM2 carriers. It demonstrated that the
lower the glycated hemoglobin (A1c) level, the lower the
risk on developing complications from such infirmity(4),
which disable the individual to perform rou-
tine and productive activities, generating
costs for society.
DM2 demands the polypharmacy practice
for its metabolic control.  Polypharmacy is a term
used to describe the daily multiple use of medi-
cations by a patient (5 or more)(5). Some studies
have characterized users of this practice(5-6).
One study affirms that individuals that
tend to practice polypharmacy are of old age,
females, under poor health condition and showing symp-
toms of depression(6). Another study presents results show-
ing that elder women with educational level up to junior
high school are more tendentious to the practice.  In this
sample, 91% used some type of medication, 33% of them
used it with no medical prescription and 27% showed evi-
dences of polypharmacy(5).
In another knowledge sphere, some studies demon-
strate higher prevalence of depression in -DM2 carriers(7-8).
One of these studies performed a systematic review be-
tween 1990 and 2001 on MEDLINE and LILACS databases,
showing that depression symptoms are related to glycemic
decompensation, to an increase and higher severity of com-
plications resulting from DM2 and the elevated impact on
the routine life of DM2 carriers(7).
Another study that aimed at identifying depression symp-
toms by the Beck Depression Inventory (BDI) in carriers of
DM2, demonstrated that 68.12% of the sample of 59 DM2
carriers showed depression symptoms higher than the cut-
off point score established by the instrument. These results
were related to females (p=0.002), older age (p<0.001) and
lower educational level (p=0.024)(8).
In order to understand these interrelations, literature
shows that as from a stressing agent, the hypophyseal
adrenocortical axis can be activated, increasing synthesis
and the liberation of cortisol, a hyperglycemia hormone
that basically damages metabolic control in DM2 carriers
leading individuals to depression(9).
Starting from that, this study aims to investigate if the
practice of polypharmacy among DM2 carriers is a stress-
ing agent capable of influencing the hypophyseal adreno-
cortical axis, leading this population to depression and, con-
sequently to the inefficient control of DM2.
Hence, three indicators were used: two regarding de-
pression measuring, one subjective (BDI)(10), and another
objective (urinary cortisol (CORT)); and one third indicator
regarding metabolic decompensation measuring that dem-
onstrates DM2 control (A1C).
OBJECTIVES
Characterize polypharmacy among DM2 carriers. Relate
polypharmacy and the number of chronic complications of
DM2 with depression symptoms indicators (BDI and CORT).
METHOD
This is a cross-sectional descriptive study.
Data were collected from DM2 carriers in the
Diabetes Control League clinics of the Gen-
eral Hospital of the University of Medicine of
São Paulo Endocrinology Discipline.
Mandatory inclusion criteria for this study
were the following: DM2 carriers at any evo-
lution phase of the disease; being 18 or older due to pecu-
liarities regarding  DM2 and depression and to ensure ethi-
cal aspects of the research; not using any anti-depressive
medications or anti-anxiety agents for a period of at least
one month before accepting to participate in this research,
in order to avoid possible humor or neuro-chemicals and
hormones influence;  accepting to participate in this re-
search and proceed with a written agreement by signing a
Free and Informed Consent Form (registered under proto-
col 468/2005 in the Research Ethics Committee of the Nurs-
ing School of the University of São Paulo).
Data were collected throughout the period of 09/28/
2005 to 03/08/2006 in a location that ensured privacy to
each collaborator, informing them to preferably not bring
any companions (family or friend), to answer the research
instruments and receive guidelines regarding CORT doses.
The amount of subjects composing the study was de-
termined by the sample calculation and the alpha risk was
lower or equal to 5% and beta risk lower or equal to 20% of
committing a type 1 or first class mistake.   A forty-carriers
of DM2 sample was considered for a 2-tailed hypothesis
for an independent and non-parametric test.
Some studies
demonstrate higher
prevalence of
depression in
Diabetes Mellitus
Type 2.
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CORT dosages (objective indicator of depression symp-
toms) were measured through the biochemical 24-hour
urine exam, using electro-immune test(11).
Applied questionnaires and instruments were composed of:
• Socio-Demographic Data Collection Questionnaire:
elaborated to characterize Gindividuals of the research re-
garding socio-demographic data (gender, age, marital sta-
tus, origin, religion/faith presence and practice, level of
education, individual income, family income, income  per
capita and people who are in charge of the income for the
whole family).
• DM2 Data Collection Questionnaire: data in this in-
strument provided information about therapeutic and clini-
cal conditions contemplating: DM2 duration, self-assess-
ment of DM2 impact over routine life (assessment through
alpha-numeric scale from 0 to 10, where 0 (zero) is equiva-
lent to no impact and 10 (ten) to maximum impact), lifestyle
(smoking(12), alcoholism(13), physical activity and eating hab-
its),  anthropometric data (weight, height, body mass in-
dex (BMI), waist circumference (WC), and waist hips ratio
(WHR)), pharmacology, dealing with the disease (daily con-
trol method for the disease and hypoglycemic crisis), and
biochemical control of the disease (A1c).
In order to analyze lifestyles regarding smoking and
drinking, two specific instruments(12-13) were used as follows.
The Fagerström test aims at assessing the nicotine de-
pendency degree as from the individual’s affirmative an-
swer regarding the smoking habit, consequently, the prob-
ability of this individual to show abstinence syndrome if,
eventually, he stops smoking; it is composed of 6 questions,
the first and fourth questions have 4 alternatives rating from
0 to 3 points and the other questions have 2 alternatives
rating from 0 to 1 points. The sum of these points, when
there are scores above or equal to 6 points, demonstrates
great dependency on nicotine and higher chances of show-
ing abstinence syndromes when stopping it. Although not
validated, this test is recommended by the National Can-
cer Institute of the Department of Health (INCA in Brazilian
acronyms)(12).
The Cage test identifies if the individual is an alcoholic
or not. It was validated for Portuguese in 1983 and is com-
posed of 4 questions, where affirmative answers are equiva-
lent to 1 point while negative answers do not add or sub-
tract points from the score, because they are equivalent to
zero. The classification occurs after the sum of the points
acquired in the affirmative answers. Therefore, when the
score is 0 to 1, the individual is not an alcoholic, when the
score is 2 points; the individual shows high risk of becom-
ing an alcoholic and when the score is between 3 and 4
points, the individual is an alcoholic(13).
In order to analyze anthropometric data, reference val-
ues alleged by the Brazilian Association for the Study of Obe-
sity and the Metabolic Syndrome(14) were uses as follows:
• Regarding BMI: Individuals with values <18.5 were
considered thin, individuals with values between 18.5  25
were considered normal, individuals between 25  30 were
considered overweight, individuals with values between 30
 40 were considered obese, and individuals with values
>40  were considered severely obese;
• Regarding WC: Women with values < 80 were consid-
ered normal, women with values > 80 were considered
having central obesity; men with values < 95 were consid-
ered normal and men with values > 95 were considered
with central obesity;
• Regarding WHR: Women with values < 0.80 were con-
sidered normal, women with values > 0.80 were consid-
ered having central obesity; men with values < 0.90 were
considered normal and men with values > 0.90 were con-
sidered with central obesity;
To analyze A1c the Performance Liquid Chromatogra-
phy (HPLC) method alleged by the Interdisciplinary Group
of A1c standardization of FENAD (National Federation of
Diabetes Associations and Entities) was used, where values
above 7% were considered as altered(15).
• Beck Depression Inventory (BDI) (16): subjective indica-
tor of depression symptoms that, according to its descrip-
tion, refer to a
[…] Depression self-assessment measure, with no diagno-
sis purpose, however serving as assessment complement;
composed of 21 symptoms and attitudes categories charac-
terized from depression manifestations. Each category con-
sists of a series of different intensity degrees of manifesta-
tions, reflecting the intensity of the symptom (from neutrality
to maximum severity), in numeric scales from 0 to 3 points.
Categories involve humor, vegetative, social withdrawal, and
cognitive and irritability manifestations. Depression symp-
toms involve the following categories according to the order
they appear in the instrument: Sadness, pessimism, failure
sensation, lack of satisfaction, guilty sensation, punishment
sensation, self-depreciation, self-accusation, suicidal ideas,
crying crisis, irritability, social isolation,  indecision, body im-
age distortion, work inhibition, sleep disorder, fatigue, appe-
tite loss, weight loss, somatic anxiety, and reduction in li-
bido. To assess the score obtained in applying the inventory,
the sum of points from all categories must be performed for
later result verification.   [...] Studies recommend that results
must be classified into three different levels of score:  from 0
to 15 points, absence of depression symptoms; scores above
15 points and bellow 20 points indicate a  dysphoria state;
and scores above 20 points indicate suggestive depression
diagnosis [...](17).
In order to analyze the internal consistence of BDI, a
Cronbach Alpha of 0.920 was used, indicating a great reli-
ability index. The index was maintained even when some
of its domains were withdrawn, proving a minimum coeffi-
cient of 0.915. It is important to stand out that the domain
Suicidal Ideas was eliminated from the analysis, since they
showed zero variance.
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RESULTS
The sample was constituted by 60% of women, 45% of
elders (60 years old or older); the age median was 56.5,
where the minimum and the maximum were, respectively,
21 to 90 years old, and the average of age was 59.8 with
standard deviation of ± 13.6 years old.
The group was composed of 52.5% in a stable relation-
ship, 22% of widowers, 15% of unmarried and 10% of sepa-
rated /divorced; 37.5% from the interior of the state of São
Paulo, 32.5% from the Great area of São Paulo, and 30%
from other States.
The whole sample (100%) affirmed having a religion and/
or faith, and within them 77.5% affirmed to practice it.
The median in the school education level was of 8 years
old. the minimum and maximum were, respectively, from
0 to 20 years, the average was 7.6 with standard deviation
of ± 4.8 years of study, 2.5% of the sample was illiterate.
Individual income varied from 1 to 20 minimum salaries
in 85% of the sample. The others had no own income and
34% of the sample were family income providers. Family in-
come varied from 1 to 15 minimum salaries and the per capita
income of 0.3 to 5 with median of 1.6 minimum salaries.
The characterization of the sample is presented as fol-
lows under various clinical aspects of DM2 (Table 1).
Table 1 - Characterization of the group studied according to clinical
aspects - São Paulo - 2005 - 2006
Variables and Categories N %
DM2 Duration
(Average / ± SD / Median, in years)
13.7 / ± 9.9 / 11.0
Number of complications that are consequences of DM2
3 or more 16 42.5
1 or 2 14 37.8
None 7 18.9
Self-assessment of the impact of dm2 on daily life
(Average / ± SD / Median)
5.8 / ± 2.5 / 6.0
Physical activity practice
No 28 70.0
Yes 12 30.0
Practicing frequency of physical activity
5 times per week 7 58.3
3 times per week 4 33.3
7 times per week 1 8.3
Following nutritional guidelines
No 22 55.0
Yes 18 45.0
Alcoholism
No 37 92.5
Yes 3 7.5
Continued...
Higher probabilities of having alcoholism. according to cage
No 35 87.5
Yes 5 12.5
Smoking
No 25 62.5
Yes 15 37.5
Higher probabilities of abstinence syndrome by
nicotine. according to Fagerström
Yes 12 80.0
No 3 20.0
Use of medications
Yes 40 100.0
Number of medications used
5 or more medications per day 35 87.5
4 medications per day 4 10.0
3 medications per day 1 2.5
Medication frequency
Up to 3 times per day 21 52.5
4 times per day 19 47.5
Using exogenous insulin
No 21 52.5
Yes 19 47.5
Glycemic control performance
No 34 85.0
Yes 6 15.0
Presence of hypoglycemic crisis
No 31 77.5
Yes 9 22.5
Frequency of hypoglycemic crisis
Once per month 6 66.7
8 times per month 2 22.2
Longer than one month interval 1 11.1
Body mass index
(Average / ± SD / Median. in kg/m )
2
28.3 / ± 4.3 / 28.3
Waist circumference alteration
Female
Male
19
10
78.0
77.0
Waist-hip ratio alteration
Female
Male
24
16
100.0
100.0
Glycated hemoglobin
(Average / ± SD / Median, in percentages) 9.1 / ± 2.2 / 9.2
Variables and Categories N %
...Continuation
The Spearman correlation test between BDI scores and
CORT dosages demonstrate a statistically significant and posi-
tive correlation between the two variables. In other words,
as the BDI score increases, higher the CORT dosage, and vice-
versa, according to what is demonstrated in Figure 1.
The medications used were:  oral anti-diabetes, insulin,
anti-high blood pressure, diuretic, antilipemic and throm-
bolytic.  In the group studied, 75% made daily use of 5 to 8
medications and 12.5% 8 medications/day or more; all sub-
jects took at least 3 medications/day; and 60% had between
1 to 3 DM2 complications and 22.5% had 3 or more.
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Figura 1 - Correlation between BDI and CORT (micrograms / 24
hrs) in carriers of DM2 - São Paulo - 2005 - 2006.
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The correlation between the number of medications and
depression indicators (BDI and CORT) were not statistically
significant (Spearman, r=0.129, p=0.427; and r=-0.019.
p=0.905, respectively).
A similar situation occurred between the number of DM2
complications and these same depression indicators (Spearman,
r=0.045, p=0.785; and r=0.084, p=0.605, respectively).
The correlation between the frequency of taking medi-
cations/day and depression indicators did not evidenced
significant statistically correlation with BDI (Spearman,
r=0.179, p=0.270).
However, calculations with CORT demonstrated posi-
tive and significant statistically correlation (Spearman,
r=0.319, p=0.019), in other words, as medication intake fre-
quency/day increases, the same occurs to CORT levels. Fig-
ure 2 shows the distribution of DM2 carriers according to
the frequency in which medications are taken daily and
CORT levels.
Figure 2 - DM2 carriers’ distribution according to the frequency
in which medication are taken (per day) and CORT (micrograms /
24 hrs). São Paulo, 2005 – 2006
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In Figure 3, firstly the study group was subdivided into
two subgroups per individuals with normal A1c and another
with altered A1c. Afterwards, the correlation of exogenous
insulin use with the presence of A1c levels alterations in
each subgroup was analyzed.
Fisher exact Test (p=0.424)
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Figue 3 -  DM2 carriers percentage distribution, according to the
use of exogenous insulin and the presence of alterations in A1c
levels. São Paulo, 2005 - 2006
Results demonstrated that in the A1c normal subgroup,
25% of individuals are medicated with exogenous insulin.
While in the altered A1c subgroup this percentage is 46.4%
(Figure 3). In addition, no association between the use of ex-
ogenous insulin with A1c levels alterations in each subgroup
were evidenced, according to Fisher Exact Test (p=0.424).
DISCUSSION
Only a few studies tried to investigate the hypophyseal
adrenocortical axis(18) activity in the DM2 context. On the
other hand, based on theoretical knowledge, it is well-
known that CORT levels trigged by a stressing agent can
cause depression and hyperglycemia symptoms(9).
Through a stressing agent, whether pleasant or not,
holding the subject as reference, this stressing agent acts
in the hypophyseal adrenocortical axis, leading the indi-
vidual to depression, through blocking serotonin receptors
5HT
1A
; and the metabolic decompensation, analyzed from
the DM2 context perspective, through the stimulation of
hepatic glyconeogenesis,  protein degradation and increase
in the number of glucocorticoid receptors in adipose tis-
sue; and the inhibition of glucose receptors in the adipose
and muscle levels (Figure 4).
HIPPOCAMPUS
5HT1A
HYPOTHALAMUS
CRH
ADENO-HYPOPHISIS STRESS DEPRESSION
ACTH
ZONA FASCULATA OF THE ADRENAL GLAND
CORTISOL
MUSCLE TISSUE LIVER ADIPOSE TISSUE
PROTEIN DEGRADATION GLYCONEOGENESIS NUMBER OF RECEPTORS
GLUCOCORTICOID
GLUT4GLUT4
Label Stimulating action Inhibitory action
Figure 4 - The intervention between cortisol, depression and dia-
betes mellitus type 2
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The experience of the chronic DM2 condition can be
characterized as stress. Chronicity can be measured by the
complications resulting from this disease and the practice
of polypharmacy. In addition to behaviors that can contrib-
ute for the development and severity of the chronic aspect.
As from the results demonstrated (Table 1), verifying
that it regards a group that has been experiencing DM2
for at least 10 years was possible, and only 18.9% of these
individuals have no complications resulting from DM2 and
classified this disease as highly impacting to their rou-
tine life.
When analyzing under the lifestyle perspective (Table
1), only 30% performed some type of physical activity,
among these, only 8.3% practiced it daily; in addition, 55%
affirmed not following nutritional guidelines and 85% do
not perform daily glycemic control.
Regarding the anthropometric profile of the group
(Table 1), which has BMI average and median of 28.3 with
standard deviation of ± 4.3, demonstrating an overweight
sample.  The female sample has an average WC measure
of 88 cm and a fraction of waist-hip ratio of 0.88; the male
sample has, respectively, 102 cm and 1.01. It regards
people with cardiovascular disease risk, developing DM2
and with tendencies to central obesity (14). In order to ag-
gravate this chart 12.5% of the group have higher prob-
abilities to show alcoholism and 37.5% affirm being smok-
ers, from these, 80% were characterized as chemical and
nicotine dependents.
Polypharmacy practice was verified(5-6) and the fre-
quency of these daily intake of medications has shown it-
self as a stressing agent, through the perspective of the
depression objective indicator (CORT).
The subjective indicator of depression (BDI) was ex-
pected to also demonstrate a significant and positive cor-
relation from the statistical point of view with the daily fre-
quency of medication intake.
In face of these results, questionings arouse about the
administration of exogenous insulin as a determining vari-
able to control DM2, in regards of medications orally admin-
istrated, and that because of this thinking, perhaps inter-
fered in the meaning of the stressing agent for DM2 carriers.
The individual with altered A1c demonstrated to use
more exogenous insulin, in comparison to those with nor-
mal A1c. However, the use or not of exogenous insulin is
indifferent to control metabolic decompensation in DM2.
Therefore, it is not a stressing agent with higher or less im-
portance in face of orally administrated medications.
In other words, what determines the increase on CORT
levels is exclusively the frequency of daily medication in-
take, meaning the times individuals daily stop to self-ad-
minister medications to control DM2.
This present research aimed at pointing out the impor-
tance of rationally adopting a pharmacology therapy, since
it can trigger collateral events apart from those once pre-
dicted, or through chemical components interactions.  In
addition, to reaffirm that the absolute number of medica-
tions in use or the absolute number of resulting complica-
tions in DM2 were not determinants of the eventual mani-
festation of depression symptoms, but, mostly probable,
the meanings printed within these events.
CONCLUSIONS
Results demonstrated that DM2 carriers practice polyp-
harmacy. However, neither the amount of medication daily
taken, nor even the use of exogenous insulin, are config-
ured as stressing agents; it is the frequency in which these
medications are daily taken.
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